0001104659-23-036164.txt : 20230323 0001104659-23-036164.hdr.sgml : 20230323 20230323200932 ACCESSION NUMBER: 0001104659-23-036164 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230321 FILED AS OF DATE: 20230323 DATE AS OF CHANGE: 20230323 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HOGUE GERALD L. CENTRAL INDEX KEY: 0001868738 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39373 FILM NUMBER: 23757485 MAIL ADDRESS: STREET 1: 4850 WEST 78TH STREET CITY: INDIANAPOLIS STATE: IN ZIP: 46268 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: POINT Biopharma Global Inc. CENTRAL INDEX KEY: 0001811764 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 850800493 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4850 WEST 78TH STREET CITY: INDIANAPOLIS STATE: IN ZIP: 46268 BUSINESS PHONE: (317) 543-9957 MAIL ADDRESS: STREET 1: 4850 WEST 78TH STREET CITY: INDIANAPOLIS STATE: IN ZIP: 46268 FORMER COMPANY: FORMER CONFORMED NAME: Therapeutics Acquisition Corp. DATE OF NAME CHANGE: 20200511 4 1 tm2310415-1_4seq1.xml OWNERSHIP DOCUMENT X0407 4 2023-03-21 0 0001811764 POINT Biopharma Global Inc. PNT 0001868738 HOGUE GERALD L. 4850 WEST 78TH STREET INDIANAPOLIS IN 46268 1 0 0 0 0 Common Stock 2023-03-21 4 M 0 17936 6.97 A 21596 D Stock Option (Right to Buy) 6.97 2023-03-21 4 M 0 17936 0 D 2026-12-01 Common Stock 17936 17936 D As previously reported in a Form 4 filed with the Securities and Exchange Commission on June 30, 2021, the reporting person received an option to purchase 35,872 shares of the issuer's common stock (the "Option"). The Option vested 25% on December 1, 2021 and 25% on December 1, 2022, and will vest 25% on December 1, 2023 and 25% on December 1, 2024. /s/ William L. Demers, by Power of Attorney for Gerald L. Hogue 2023-03-23